Quanterix Corp
For the period ended Dec 31, 2025. Filed Mar 2, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 2, 2026
QTRX$3.28-3.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cash flows from operating activities: | |||
| Net loss | $(107,150) | $(38,531) | $(28,354) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization expense | 15,844 | 6,463 | 6,275 |
| Credit losses on accounts receivable | 628 | 588 | 336 |
| Accretion of marketable securities | (2,078) | (6,833) | (1,964) |
| Operating lease right-of-use asset amortization | 3,081 | 1,893 | 2,015 |
| Stock-based compensation expense | 20,718 | 19,987 | 16,823 |
| Impairment | 7,752 | — | 1,361 |
| Change in fair value of contingent liabilities | (4,547) | — | — |
| Recognition of off-market liability | (2,726) | — | — |
| Deferred taxes | (5,867) | (290) | (290) |
| Other operating activity | (540) | 345 | 140 |
| Changes in assets and liabilities: | |||
| Accounts receivable | 10,609 | (7,704) | (6,695) |
| Inventory | 4,033 | (6,679) | (8,944) |
| Prepaid expenses and other current assets | 3,521 | (443) | (2,371) |
| Other non-current assets | 252 | (1,215) | (717) |
| Accounts payable | (528) | 723 | 1,189 |
| Accrued compensation and benefits, accrued expenses, and other current liabilities | (7,914) | 1,398 | 4,410 |
| Net change in other operating assets and liabilities | (12,324) | (4,866) | (2,063) |
| Net cash used in operating activities | (77,236) | (35,164) | (18,849) |
| Cash flows from investing activities: | |||
| Purchases of marketable debt securities | (69,757) | (295,606) | (175,613) |
| Proceeds from sales and maturities of marketable securities | 215,829 | 216,709 | 31,000 |
| Purchases of property and equipment | (2,612) | (3,368) | (3,841) |
| Acquisitions, net of cash acquired | (93,229) | — | — |
| Net cash provided by (used in) investing activities | 50,231 | (82,265) | (148,454) |
| Cash flows from financing activities: | |||
| Proceeds from common stock issued under stock plans | 738 | 3,066 | 2,889 |
| Payments for employee taxes withheld on stock-based compensation awards | (1,446) | (2,610) | (198) |
| Net cash provided by (used in) financing activities | (708) | 456 | 2,691 |
| Net decrease in cash, cash equivalents, and restricted cash | (27,713) | (116,973) | (164,612) |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 1,574 | (734) | 301 |
| Cash, cash equivalents, and restricted cash at beginning of period | 59,319 | 177,026 | 341,337 |
| Cash, cash equivalents, and restricted cash at end of period | $33,180 | $59,319 | $177,026 |
| Supplemental disclosure of cash flow information: | |||
| Common stock issued in exchange for acquisition of Akoya (Note 3) | $49,900 | $— | $— |
| Purchases of property and equipment in accounts payable and accruals | $121 | $1,230 | $419 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.